The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this “Connectivity Map” resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, post-perturbation transcriptomics data are particularly suited for training computational models because the causal relationship between known perturbations (cause) and the measured post-perturbation gene expression (effect) allows for the modelling of mechanistic processes [11].”
From Benchmarking foundation cell models for post-perturbation RNA-seq prediction (2025) · cites this paper as [11]
In the citing paper
“Both Alakwaa’ and Luo’s pipelines use the CLUE platform, a cloud-based platform developed by the LINCS Center for signature-gene based drug ranking61.”
From ASGARD is a single-cell guided pipeline to aid repurposing of drugs (2023) · cites this paper as [61]
In the citing paper
“For example, in a classic paradigm inflammatory bowel disease (IBD) signatures were derived from surgical specimens and intersected with Connectivity Map70 data representing transcriptional readouts across a number of cell lines in response to treatment with many hundreds of drugs using a novel pattern-matching algorithm71. From this research the anticonvulsant drug topiramate was identified and”
From Exploiting machine learning for end-to-end drug discovery and development (2019) · cites this paper as [71]
In the citing paper
“Useful tools will include maps of evolutionary conservation (108) and chromatin state (140), as well as databases of cell-state signatures, such as genome-wide expression patterns, that may integrate aspects of cell biology under resting and provoked conditions (141).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [141]
In the citing paper
“It has been shown that compounds eliciting similar transcriptional signatures tend to share mechanisms of action.170,207−209”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [207]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Self-citationMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533
Research works printed but not linked: 7
- K. B. Glaser et al., Mol. Cancer Ther.2, 151 (2003).
- A. E. Wakeling, M. Dukes, J. Bowler, Cancer Res.51, 3867 (1991).
- J. Y. Vanderhoek, M. B. Feinstein, Mol. Pharmacol.16, 171 (1979).
- H. Hieronymus et al. Cancer Cell in press.
- Q. Yao et al., Clin. Cancer Res.9, 4483 (2003).
- T. Kubota et al., Cancer Res.58, 3344 (1998).
- G. Wei et al. Cancer Cell in press.
Cited by
Items 501–600 of 1,037
Weinstein, J. N. (2012) · Nature · doi:10.1038/483544a · Cited by 121
Suppression of the HSF1‐mediated proteotoxic stress response by the metabolic stress sensor AMPK
Dai, S., Tang, Z., Cao, J., Zhou, W. Y., Li, H., Sampson, S. B., & Dai, C. (2014) · The EMBO Journal · doi:10.15252/embj.201489062 · Cited by 122
Phenotypic Profiling of Antibiotic Response Signatures in Escherichia coli Using Raman Spectroscopy
Athamneh, A. I. M., Alajlouni, R. A., Wallace, R. S., Seleem, M. N., & Senger, R. S. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02098-13 · Cited by 121
The limitations of simple gene set enrichment analysis assuming gene independence
Tamayo, P., Steinhardt, G., Liberzon, A., & Mesirov, J. P. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280212460441 · Cited by 125
Kohonen, P., Parkkinen, J. A., Willighagen, E. L., Ceder, R., Wennerberg, K., Kaski, S., & Grafström, R. C. (2017) · Nature Communications · doi:10.1038/ncomms15932 · Cited by 110
A STAT3-based gene signature stratifies glioma patients for targeted therapy
Tan, M. S. Y., Sandanaraj, E., Chong, Y. K., Lim, S. W., Koh, L., Ng, W. H., Tan, N. S., Tan, P. B. O., Ang, B. T., & Tang, C. (2019) · Nature Communications · doi:10.1038/s41467-019-11614-x · Cited by 120
Computational systems biology in disease modeling and control, review and perspectives
Yue, R., & Dutta, A. (2022) · npj Systems Biology and Applications · doi:10.1038/s41540-022-00247-4 · Cited by 120
Network analysis of FDA approved drugs and their targets
Ma’ayan, A., Jenkins, S. L., Goldfarb, J., & Iyengar, R. (2007) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20002 · Cited by 120
Managing the sequence-specificity of antisense oligonucleotides in drug discovery
Hagedorn, P., Hansen, B. R., Koch, T., & Lindow, M. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx056 · Cited by 120
TGF-β promotes microtube formation in glioblastoma through thrombospondin 1
Joseph, J. V., Magaut, C., Storevik, S., Geraldo, L. H., Mathivet, T., Latif, A., Rudewicz, J., Guyon, J., Gambaretti, M., Haukås, F., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab212 · Cited by 119
Drug target prediction through deep learning functional representation of gene signatures
Chen, H., King, F. J., Zhou, B., Wang, Y., Canedy, C. J., Hayashi, J., Zhong, Y., Chang, M. W., Pache, L., Wong, J. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46089-y · Cited by 119
Aberrant cytokine signaling in leukemia
Etten, R. A. V. (2007) · Oncogene · doi:10.1038/sj.onc.1210758 · Cited by 121
Widespread parainflammation in human cancer
Aran, D., Lasry, A., Zinger, A., Biton, M., Pikarsky, E., Hellman, A., Butte, A. J., & Ben-Neriah, Y. (2016) · Genome Biology · doi:10.1186/s13059-016-0995-z · Cited by 109
Taubes, A., Nova, P., Zalocusky, K. A., Kosti, I., Bicak, M., Zilberter, M. Y., Hao, Y., Yoon, S. Y., Oskotsky, T., Pineda, S., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00122-7 · Cited by 118
gene2drug: a computational tool for pathway-based rational drug repositioning
Napolitano, F., Carrella, D., Mandriani, B., Pisonero-Vaquero, S., Sirci, F., Medina, D. L., Brunetti-Pierri, N., & di Bernardo, D. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx800 · Cited by 108
Screening of natural products for therapeutic activity against solid tumors.
El-Menshawi, B. S., Fayad, W., Mahmoud, K. M., El-hallouty, S. M., El‐Manawaty, M. A., Olofsson, M. H., & Linder, S. T. (2010) · PubMed · Cited by 118
Disease signatures are robust across tissues and experiments
Dudley, J. T., Tibshirani, R., Deshpande, T., & Butte, A. J. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.66 · Cited by 110
Ye, R., Tan, C., Chen, M., Liang, H., Ji, L., & Mao, Z. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201505160 · Cited by 118
Lv, C., Wu, X., Wang, X., Su, J., Zeng, H., Zhao, J., Lin, S., Liu, R., Li, H., Li, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00535-8 · Cited by 117
Mitchell, K. A., Zingone, A., Toulabi, L., Boeckelman, J., & Ryan, B. M. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0527 · Cited by 117
Optimization of Encoded Hydrogel Particles for Nucleic Acid Quantification
Pregibon, D. C., & Doyle, P. S. (2009) · Analytical Chemistry · doi:10.1021/ac9005292 · Cited by 117
Blueprint for antimicrobial hit discovery targeting metabolic networks
Shen, Y., Liu, J., Estiu, G., Isin, B., Ahn, Y.-Y., Lee, D.-S., Barabási, A.-L., Kapatral, V., Wiest, O., & Oltvai, Z. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909181107 · Cited by 106
Hong, J. S., Arneson, D. V., Umar, S., Ruffenach, G., Cunningham, C. M., Ahn, I. S., Diamante, G., Bhetraratana, M., Park, J. F., Said, E., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202006-2169oc · Cited by 116
Pharmacogenomics in Alzheimer's Disease
Cacabelos, R. (2008) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-205-2_10 · Cited by 109
Chen, B., Wei, W., Ma, L., Yang, B., Gill, R. M., Chua, M.-S., Butte, A. J., & So, S. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.039 · Cited by 98
A survey of gene expression meta-analysis: methods and applications
Toro‐Domínguez, D., Villatoro-García, J. A., Martorell‐Marugán, J., Montoya, Y. R., Alarcón-Riquelme, M. E., & Carmona‐Sáez, P. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa019 · Cited by 115
Le‐Niculescu, H., McFarland, M. J., Ogden, C. A., Balaraman, Y., Patel, S., Tan, J., Rodd, Z. A., Paulus, M., Geyer, M. A., Edenberg, H. J., et al. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30707 · Cited by 111
van Noort, V., Schölch, S., Iskar, M., Zeller, G., Ostertag, K., Schweitzer, C., Werner, K., Weitz, J., Koch, M., & Bork, P. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3540 · Cited by 104
Gene-expression profiling in epithelial ovarian cancer
Konstantinopoulos, P. A., Spentzos, D., & Cannistra, S. A. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1178 · Cited by 115
Targeting acute myeloid leukemia by drug-induced c-MYB degradation
Walf-Vorderwülbecke, V., Pearce, K., Brooks, T., Hubank, M. J. F., van den Heuvel‐Eibrink, M. M., Zwaan, C. M., Adams, S. P., Edwards, D., Bartram, J. L., Samarasinghe, S., et al. (2017) · Leukemia · doi:10.1038/leu.2017.317 · Cited by 115
Developmental neuroscience perspectives on emotion regulation
Goldsmith, H. H., Pollak, S. D., & Davidson, R. J. (2008) · Child Development Perspectives · doi:10.1111/j.1750-8606.2008.00055.x · Cited by 114
“The development of all human characteristics is genetically influenced, in the sense that the genetic code carries transmissible information to assemble and regulate the organism (Lamb et al., 2006).”
BackgroundEfficient Generation of Transcriptomic Profiles by Random Composite Measurements
Cleary, B., Cong, L., Cheung, A., Lander, E. S., & Regev, A. (2017) · Cell · doi:10.1016/j.cell.2017.10.023 · Cited by 114
Self-citationZhang, W., Voloudakis, G., Rajagopal, V. M., Readhead, B., Dudley, J. T., Schadt, E. E., Björkegren, J. L. M., Kim, Y., Fullard, J. F., Hoffman, G. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11874-7 · Cited by 96
Independent component analysis: Mining microarray data for fundamental human gene expression modules
Engreitz, J., Daigle, B. J., Marshall, J. J., & Altman, R. B. (2010) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2010.07.001 · Cited by 115
Wozniak, M. B., Villuendas, R., Bischoff, J. R., Aparicio, C. B., Martínez-Leal, J. F., de la Cueva, P., Rodríguez, M. E., Herreros, B., Martín-Pérez, D., Longo, M. I., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.013870 · Cited by 114
Supporting read-across using biological data
Zhu, H. (2016) · ALTEX · doi:10.14573/altex.1601252 · Cited by 102
Effective knowledge management in translational medicine
Szalma, S., Koka, V., Khasanova, T., & Perakslis, E. D. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-68 · Cited by 96
A Genomic Strategy to Elucidate Modules of Oncogenic Pathway Signaling Networks
Chang, J. T., Carvalho, C., Mori, S., Bild, A. H., Gatza, M. L., Wang, Q., Lucas, J. E., Potti, A., Febbo, P. G., West, M., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.030 · Cited by 107
Search Algorithms as a Framework for the Optimization of Drug Combinations
Calzolari, D., Bruschi, S., Coquin, L., Schofield, J., Feala, J. D., Reed, J. C., McCulloch, A. D., & Paternostro, G. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000249 · Cited by 101
Systematic analysis of genome-wide fitness data in yeast reveals novel gene function and drug action
Hillenmeyer, M. E., Ericson, E., Davis, R. W., Nislow, C., Koller, D., & Giaever, G. (2010) · Genome Biology · doi:10.1186/gb-2010-11-3-r30 · Cited by 112
“For example, one such approach [17] looks for similarities in gene expression profiles in response to the drug; whereas another [18] looks for similarities in side effects.”
BackgroundZhang, M., Lu, Q., Wu, W., Niu, X., Wang, C., Feng, Y., Xu, Q. J., Wang, S., Yuan, X., Yu, H., et al. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.00678 · Cited by 112
Guo, T., Yang, J., Li, D., Sun, K., Luo, L., Xiao, W., Wang, J., Liu, Y., Wang, S., Wang, H., et al. (2019) · Molecular Breeding · doi:10.1007/s11032-019-0993-4 · Cited by 112
Corsi, S. R., DeCicco, L., Villeneuve, D. L., Blackwell, B. R., Fay, K. A., Ankley, G. T., & Baldwin, A. K. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.05.457 · Cited by 112
Stockwell, S. R., Platt, G., Barrie, S. E., Zoumpoulidou, G., te Poele, R. H., Aherne, G. W., Wilson, S. C., Sheldrake, P., McDonald, E., Venet, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028568 · Cited by 108
Peltonen, K., Colis, L., Liu, H., Jäämaa, S., Moore, H. M., Enbäck, J., Laakkonen, P., Vaahtokari, A., Jones, R. J., af Hällström, T. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012996 · Cited by 99
The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells
Khor, B., Gagnon, J. D., Goel, G., Roche, M. I., Conway, K. L., Tran, K., Aldrich, L. N., Sundberg, T. B., Paterson, A. M., Mordecai, S., et al. (2015) · eLife · doi:10.7554/elife.05920 · Cited by 106
Yang, L., Wang, K., Chen, J., Jegga, A. G., Luo, H., Shi, L., Wan, C., Guo, X., Qin, S., He, G., et al. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002016 · Cited by 103
Glorioso, C., Oh, S., Douillard, G. G., & Sibille, E. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.016 · Cited by 103
DiseaseConnect: a comprehensive web server for mechanism-based disease–disease connections
Liu, C.-C., Tseng, Y.-T., Li, W., Wu, C.-Y., Mayzus, I., Rzhetsky, A., Sun, F., Waterman, M., Chen, J. J. W., Chaudhary, P. M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku412 · Cited by 107
Shameer, K., Glicksberg, B. S., Hodos, R., Johnson, K. W., Badgeley, M. A., Readhead, B., Tomlinson, M. S., O’Connor, T., Miotto, R., Kidd, B. A., et al. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbw136 · Cited by 103
Xie, J., Ma, A., Fennell, A. Y., Ma, Q., & Zhao, J. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby014 · Cited by 113
Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs
Niculescu, A. B., Le-Niculescu, H., Levey, D. F., Roseberry, K., Soe, K. C., Rogers, J., Khan, F., Jones, T., Judd, S., McCormick, M. A., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0345-5 · Cited by 111
Probing the role of HDACs and mechanisms of chromatin-mediated neuroplasticity
Haggarty, S. J., & Tsai, L.-H. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.04.009 · Cited by 100
Self-citationSiu, F., Ma, D., Cheung, Y., Lok, C., Yan, K. H., Yang, Z., Yang, M., Xu, S., Ko, B. C. B., He, Q., et al. (2008) · PROTEOMICS · doi:10.1002/pmic.200700829 · Cited by 111
Li, H., Hyduke, D. R., Chen, R., Heard, P. L., Yauk, C. L., Aubrecht, J., & Fornace, A. J. (2015) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21941 · Cited by 111
Systems Pharmacology: Defining the Interactions of Drug Combinations
van Hasselt, J. G. C., & Iyengar, R. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021511 · Cited by 111
Identifying Network of Drug Mode of Action by Gene Expression Profiling
Iorio, F., Tagliaferri, R., & Bernardo, D. D. (2009) · Journal of Computational Biology · doi:10.1089/cmb.2008.10tt · Cited by 101
Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer
Heinonen, H., Nieminen, A. I., Saarela, M., Kallioniemi, A. H., Klefström, J. T., Hautaniemi, S., & Monni, O. M. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-348 · Cited by 109
Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond
Mao, L., Lu, J., Wen, X., Song, Z., Sun, C., Zhao, Y., Huang, F., Chen, S., Jiang, D., Che, W., et al. (2025) · Chemical Society Reviews · doi:10.1039/d5cs00083a · Cited by 110
The Mycobacterium tuberculosis Drugome and Its Polypharmacological Implications
Kinnings, S., Xie, L., Fung, K. H., Jackson, R. M., Xie, L., & Bourne, P. E. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000976 · Cited by 109
Schulze, C. J., Bray, W. M., Woerhmann, M. H., Stuart, J., Lokey, R. S., & Linington, R. G. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.12.007 · Cited by 91
Drug repositioning for Alzheimer’s disease based on systematic “omics” data mining
Zhang, M., Schmitt-Ulms, G., Sato, C., Xi, Z., Zhang, Y., Zhou, Y., St George-Hyslop, P., & Rogaeva, E. (2016) · PLOS ONE · doi:10.1371/journal.pone.0168812 · Cited by 108
Yang, J., Sun, K., Li, D., Luo, L., Liu, Y., Huang, M., Yang, G., Liu, H., Wang, H., Chen, Z., et al. (2019) · BMC Genomics · doi:10.1186/s12864-019-5741-y · Cited by 108
A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
Srivastava, P. K., van Eyll, J. M., Godard, P., Mazzuferi, M., Delahaye‐Duriez, A., Steenwinckel, J. V., Gressèns, P., Danis, B., Vandenplas, C., Foerch, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06008-4 · Cited by 111
Patient-derived cell line, xenograft and organoid models in lung cancer therapy
Huo, K.-G., D’Arcangelo, E., & Tsao, M. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-154 · Cited by 108
Kim, J., Zhang, J., Cha, Y., Kolitz, S., Funt, J., Escalante Chong, R., Barrett, S., Kusko, R., Zeskind, B., & Kaufman, H. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02430-9 · Cited by 103
Understanding resistance to combination chemotherapy
Pritchard, J. R., Lauffenburger, D. A., & Hemann, M. T. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.10.003 · Cited by 110
Verbist, B., Klambauer, G., Vervoort, L., Talloen, W., Shkedy, Z., Thas, O., Bender, A., Göhlmann, H. W. H., & Hochreiter, S. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.014 · Cited by 96
Regulation of zebrafish sleep and arousal states: current and prospective approaches
Chiu, C. N., & Prober, D. A. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00058 · Cited by 96
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
Morselli Gysi, D., do Valle, Í., Zitnik, M., Ameli, A., Gan, X., Varol, O., Ghiassian, S. D., Patten, J. J., Davey, R. A., Loscalzo, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025581118 · Cited by 107
Comprehensive Analysis of Transcriptome Sequencing Data in the Lung Tissues of COPD Subjects
Kim, W. J., Lim, J. H., Lee, J., Lee, S., Kim, J. H., & Oh, Y. (2015) · International Journal of Genomics · doi:10.1155/2015/206937 · Cited by 107
p38 Mitogen-activated protein kinase stabilizes SMN mRNA through RNA binding protein HuR
Farooq, F., Balabanian, S., Liu, X., Holcik, M., & MacKenzie, A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp352 · Cited by 92
Drug Repositioning for Diabetes Based on 'Omics' Data Mining
Zhang, M., Luo, H., Xi, Z., & Rogaeva, E. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126082 · Cited by 95
Biology and therapeutic potential of PI3K signaling in ER+/HER2-negative breast cancer
Fu, X., Osborne, C., & Schiff, R. (2013) · Breast · doi:10.1016/j.breast.2013.08.001 · Cited by 81
Novel pharmacological strategies to treat cystic fibrosis
Hanrahan, J. W., Sampson, H. M., & Thomas, D. Y. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.11.006 · Cited by 106
Chapman, C. M., Sun, E. X., Roschewski, M. J., Aue, G., Farooqui, M., Stennett, L. S., Gibellini, F., Arthur, D. C., Pérez‐Galán, P., & Wiestner, A. U. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2113 · Cited by 106
Lyu, M., Yan, C.-L., Liu, H., Wang, T.-Y., Shi, X., Liu, J., Orgah, J. O., Fan, G., Han, J., Wang, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14692-3 · Cited by 106
Wang, X., Zhu, H., Jiang, Y., Li, Y., Tang, C., Chen, X., Li, Y., Liu, Q., & Liu, Q. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab587 · Cited by 106
Gao, K., Liu, L., Lei, S., Li, Z. N., Huo, P., Wang, Z., Dong, L., Deng, W., Bu, D., Zeng, X., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1037 · Cited by 108
A mammalian functional-genetic approach to characterizing cancer therapeutics
Jiang, H., Pritchard, J. R., Williams, R. T., Lauffenburger, D. A., & Hemann, M. T. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.503 · Cited by 106
Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening
Woo, H. G., Park, E. S., Lee, J., Lee, Y.-H., Ishikawa, T., Kim, Y. J., & Thorgeirsson, S. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0164 · Cited by 106
Mentzen, W. I., Peng, J., Ransom, N., Nikolau, B. J., & Wurtele, E. S. (2008) · BMC Plant Biology · doi:10.1186/1471-2229-8-76 · Cited by 106
Big data: the next frontier for innovation in therapeutics and healthcare
Issa, N. T., Byers, S. W., & Dakshanamurthy, S. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.905201 · Cited by 92
Yang, L., Chen, J., & He, L. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000441 · Cited by 99
Optimization of drug combinations using Feedback System Control
Nowak-Sliwinska, P. M., Weiss, A., Ding, X., Dyson, P. J., van den Bergh, H., Griffioen, A. W., & Ho, C. (2016) · Nature Protocols · doi:10.1038/nprot.2016.017 · Cited by 105
Network Pharmacology: Exploring the Resources and Methodologies
Junaid, M., Khan, A., Ali, A., Fang, L., Yanjing, W., Xu, Q., & Wei, D. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180330141351 · Cited by 106
Interpreting pathways to discover cancer driver genes with Moonlight
Colaprico, A., Olsen, C., Bailey, M. H., Odom, G., Terkelsen, T., Silva, T. C., Olsen, A. V., Cantini, L., Zinovyev, A. Y., Barillot, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13803-0 · Cited by 105
Tong, X., Qu, N., Kong, X., Ni, S., Zhou, J., Wang, K., Zhang, L., Wen, Y., Shi, J., Zhang, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49620-3 · Cited by 105
Chemistry and Biology of Deoxynyboquinone, a Potent Inducer of Cancer Cell Death
Bair, J. S., Palchaudhuri, R., & Hergenrother, P. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100610m · Cited by 107
High-throughput electronic biology: mining information for drug discovery
Loging, W., Harland, L., & Williams–Jones, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2265 · Cited by 105
Whole-genome sequence-based analysis of thyroid function
Taylor, P. N., Porcu, E., Chew, S., Campbell, P. J., Traglia, M., Brown, S. J., Mullin, B. H., Shihab, H. A., Min, J., Walter, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms6681 · Cited by 104
The Chemical Basis of Pharmacology
Keiser, M. J., Irwin, J. J., & Shoichet, B. K. (2010) · Biochemistry · doi:10.1021/bi101540g · Cited by 94
Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway
Brum, A. M., van de Peppel, J., van der Leije, C. S., Schreuders-Koedam, M., Eijken, M., van der Eerden, B. C. J., & van Leeuwen, J. P. T. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501597112 · Cited by 98
Precision medicine for suicidality: from universality to subtypes and personalization
Niculescu, A. B., Le-Niculescu, H., Levey, D. F., Phalen, P. L., Dainton, H. L., Roseberry, K., Niculescu, E. M., Niezer, J. O., Williams, A., Graham, D. L., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.128 · Cited by 93
From genetic associations to genes: methods, applications, and challenges
Qi, T., Song, L., Guo, Y., Chen, C., & Yang, J. (2024) · Trends in Genetics · doi:10.1016/j.tig.2024.04.008 · Cited by 105
Systems biology in drug discovery and development
Berg, E. L. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.003 · Cited by 105
Jin, G., Fu, C., Zhao, H., Cui, K., Chang, J. C., & Wong, S. T. C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2333 · Cited by 104
Hsp90 regulation of fibroblast activation in pulmonary fibrosis
Sontake, V., Wang, Y., Kasam, R. K., Sinner, D., Reddy, G. B., Naren, A. P., McCormack, F. X., White, E. S., Jegga, A. G., & Madala, S. K. (2017) · JCI Insight · doi:10.1172/jci.insight.91454 · Cited by 100
Niepel, M., Hafner, M., Duan, Q., Wang, Z., Paull, E. O., Chung, M., Lu, X., Stuart, J. M., Golub, T. R., Subramanian, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01383-w · Cited by 97
Self-citationYe, R., Tan, C., Ji, L., & Mao, Z. (2016) · Dalton Transactions · doi:10.1039/c6dt00601a · Cited by 103
Metadata
- Authors
- Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G., Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Crawford, Emily D.
- Golub, Todd R.
- ORCID
- Venue
- Science
- Published
- 2006-09-29
- Volume
- 313
- Issue
- 5795
- Pages
- 1929-1935
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2121604817
- Cited by
- 5,257
- References
- 41
- Citations by year
- 2026: 226 · 2025: 285 · 2024: 332 · 2023: 370 · 2022: 416 · 2021: 406 · 2020: 383 · 2019: 385 · 2018: 280 · 2017: 288 · 2016: 296 · 2015: 259 · 2014: 217 · 2013: 241 · 2012: 219
- FWCI
- 118.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene expression signatures, small molecules, drug action, gene perturbation, mechanism of action, cultured human cells, functional genomics
- MeSH terms
- Alzheimer Disease, Cell Line, Dexamethasone, Drug Evaluation, Preclinical, Enzyme Inhibitors, Estrogens, Humans, Obesity, Phenothiazines, Software, Gene Expression, Databases, Factual, HSP90 Heat-Shock Proteins, Drug Resistance, Neoplasm, Sirolimus, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Limonins, Cell Line, Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.